Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity
Authors
Keywords
-
Journal
Science China-Life Sciences
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-06-10
DOI
10.1007/s11427-023-2378-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monkeypox virus (MPXV) genomics: A mutational and phylogenomic analyses of B.1 lineages
- (2023) Nicolas Luna et al. Travel Medicine and Infectious Disease
- Rational development of multicomponent mRNA vaccine candidates against mpox
- (2023) Rong-Rong Zhang et al. Emerging Microbes & Infections
- Targeted inhibition of Zika virus infection in human cells by CRISPR-Cas13b
- (2022) Ping Chen et al. VIRUS RESEARCH
- The changing epidemiology of human monkeypox—A potential threat? A systematic review
- (2022) Eveline M. Bunge et al. PLoS Neglected Tropical Diseases
- Delivery Strategies for mRNA Vaccines
- (2022) Sivakumar Ramachandran et al. Pharmaceutical Medicine
- Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
- (2022) Antti Hurme et al. Frontiers in Immunology
- Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
- (2022) Agam K. Rao et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus
- (2022) Joana Isidro et al. NATURE MEDICINE
- Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
- (2022) John P. Thornhill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Monkeypox Virus Infection in the Immediate Period After Receiving Modified Vaccinia Ankara Vaccine
- (2022) Aniruddha Hazra et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals
- (2022) Luca M. Zaeck et al. NATURE MEDICINE
- T cell immunity to COVID-19 vaccines
- (2022) E. John Wherry et al. SCIENCE
- Current progress in the development of prophylactic and therapeutic vaccines
- (2022) Tingting Li et al. Science China-Life Sciences
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
- (2021) Amarendra Pegu et al. SCIENCE
- Proteomic assessment of humoral immune responses in smallpox vaccine recipients
- (2021) Richard B. Kennedy et al. VACCINE
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
- (2020) Xintian Xu et al. Science China-Life Sciences
- NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
- (2020) Birkir Reynisson et al. NUCLEIC ACIDS RESEARCH
- Interfering with retrotransposition by two types of CRISPR effectors: Cas12a and Cas13a
- (2020) Niubing Zhang et al. Cell Discovery
- Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus
- (2020) Yuhong Xiao et al. VACCINE
- Exportation of Monkeypox Virus From the African Continent
- (2020) Matthew R Mauldin et al. JOURNAL OF INFECTIOUS DISEASES
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Hemagglutinin-specific CD4 + T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans
- (2017) Shuguang Tan et al. VACCINE
- Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
- (2016) Brett W. Petersen et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Phase II randomized, double-blinded comparison of a single high dose (5×108 TCID50) of modified vaccinia Ankara compared to a standard dose (1×108 TCID50) in healthy vaccinia-naïve individuals
- (2014) Sharon E. Frey et al. VACCINE
- Assessment of the Protective Effect of Imvamune and Acam2000 Vaccines against Aerosolized Monkeypox Virus in Cynomolgus Macaques
- (2013) G. J. Hatch et al. JOURNAL OF VIROLOGY
- Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response
- (2013) Nir Paran et al. Virology Journal
- ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile
- (2010) Aysegul Nalca et al. Drug Design Development and Therapy
- Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal Study
- (2008) Dennis D. Taub et al. AMERICAN JOURNAL OF MEDICINE
- Monkeypox virus and insights into its immunomodulatory proteins
- (2008) Jessica R. Weaver et al. IMMUNOLOGICAL REVIEWS
- Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies
- (2008) Joseph W. Golden et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started